Khrom Capital Management’s Soleno Therapeutics SLNO Stock Holding History

Khrom Capital Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,511,481	Closed	-$50.6M	–	17
2026 Q1	$50.6M	Buy	+1,511,481	New	+$59.3M	4.63%	11

Khrom Capital Management's SLNO Position: Q2 2026 in Review

Khrom Capital Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 1,511,481 shares — an estimated $50.6M sold.

Khrom Capital Management first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $50.6M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Khrom Capital Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Khrom Capital Management sold 1,511,481 Soleno Therapeutics shares in Q2 2026, an estimated $50.6M.
Khrom Capital Management first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Khrom Capital Management's Soleno Therapeutics position peaked at $50.6M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Khrom Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.